ReviewEndocrine reviews2022

Myostatin/Activin Receptor Ligands in Muscle and the Development Status of Attenuating Drugs.

Buel D Rodgers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.